Description
RENEW technology is based on the development of new conduits made from Wharton’s jelly hydrogels that facilitate nerve axonal regeneration. These conduits are intended for use as allografts in patients with facial nerve or other peripheral nerve injuries.
This technology eliminates the need for xenogeneic materials, thereby reducing the transmission of pathogens or allergens, and minimizes fibrosis compared to synthetic conduits.
Partnership: Co-development, Licensing
IP: Patent
TRL: 3